Loading...
Target Populations: U.S.-based infectious disease, HIV-specific, and primary care providers and public health officials
The system for rating recommendations (and the quality of evidence supporting them) has been improved. Recommendations for managing cytomegalovirus and varicella-zoster virus ocular disease have been revised because the ganciclovir ocular implant is no longer available in the U.S.
New information is provided on when to start antiretroviral therapy after diagnosis of an acute opportunistic infection (OI), including tuberculosis.
Su…